MMPAD Madrid Meeting Report

MEETING REPORT 21 European Roadshow - Friday 15th June 2018 Madrid, Spain 50. Thalange N, Deeb L, Iotova V, et al. Insulin degludec in combination with bolus insulin aspart is safe and effective in children and adolescents with type 1 diabetes. Pediatr Diabetes 2015; 16: 164-76. 51. Klinkert C, Bachran R, Heidtmann B, Grabert M, Holl RW. Age-specific characteristics of the basal insulin-rate for pediatric patients on CSII. Exp Clin Endocrinol Diabetes 2008; 116: 118-22. 52. Rewers MJ1, Pillay K, De Beaufort C, et al. International Society for Pediatric and Adolescent Diabetes ISPAD Clinical Practice Consensus Guidelines 2014. Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatr Diabetes 2014; 15 (Suppl 20): 102- 14. 53. Korkmaz Ö, Demir G, Çetin H, et al. Effectiveness of Continuous Subcutaneous Insulin Infusion Pump Therapy During Five Years of Treatment on Metabolic Control in Children and Adolescents with Type 1 Diabetes Mellitus. J Clin Res Pediatr Endocrinol 2018; 10: 147-52. 54. Danne T, Schwandt A, Biester T, et al. Long-term study of tubeless insulin pump therapy compared to multiple daily injections in youth with type 1 diabetes: Data from the German/Austrian DPV registry. Pediatr Diabetes 2018; 19: 979-84. 55. Maiorino MI, Bellastella G, Casciano O, et al. The Effects of Subcutaneous Insulin Infusion Versus Multiple Insulin Injections on Glucose Variability in Young Adults with Type 1 Diabetes: The 2-Year Follow-Up of the Observational METRO Study. Diabetes Technol Ther 2018; 20: 117-26. 56. Rankin D, Harden J, Noyes K, Waugh N, Barnard K, Lawton J. Parents’ experiences of managing their child’s diabetes using an insulin pump: a qualitative study. Diabet Med 2015; 32: 627-34. 57. Massa GG, Gys I, Op’t Eyndt A, et al. Evaluation of the FreeStyle ® Libre Flash Glucose Monitoring System in Children and Adolescents with Type 1 Diabetes. Horm Res Paediatr 2018; 89: 189-99. 58. Beck RW, Riddlesworth T, Ruedy K, et al. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections The DIAMOND Randomized Clinical Trial. JAMA 2017; 317: 371-8. 59. Lind M, Polonsky W, Hirsch IB, et al. Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial. JAMA 2017; 317: 379-87. 60. Laffel LM, Aleppo G, Buckingham BA et al. A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System to Manage Children and Adolescents With Diabetes. J Endocr Soc 2017; 1: 1461-76. 61. Kovatchev BP. Hypoglycemia Reduction and Accuracy of Continuous Glucose Monitoring. Diabetes Technol Ther 2015; 17: 530-3. 62. Chase HP. Prevention of Hypoglycemia Using the Predicted Low Glucose Suspend System. Diabetes Technol Ther 2016; 18: 276-7. 63. Abraham MB, Nicholas JA, Smith GJ, et al; PLGM Study Group. Reduction in Hypoglycemia With the Predictive Low-Glucose Management System: A Long-Term Randomized Controlled Trial in Adolescents With Type 1 Diabetes. Diabetes Care . 2018;41:303-10.